OB/GYN and Women's Health

Episodes 1-11 of 11

• 

  RestartResume

  EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i

  Medical Industry Feature

  EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Virginia Kaklamani, MD

    Peer

  • 

    

    Anne O'Dea, MD

    Peer

• 

  RestartResume

  Advancing the Transabdominal Cerclage Through Robotics

  Medical Industry Feature

  Advancing the Transabdominal Cerclage Through Robotics

  • 

    

    Arnold Advincula, MD

    Peer

• 

  RestartResume

  Expert Insights and Clinical Strategies for Postpartum Depression Screening

  Medical Industry Feature

  Expert Insights and Clinical Strategies for Postpartum Depression Screening

  • 

    

    Jennifer L. Payne, MD

    Peer

  • 

    

    Melissa Simon, MD

    Peer

• 

  RestartResume

  Navigating How the Updated ASCCP Guidelines Can Work for You
  

  Medical Industry Feature

  Navigating How the Updated ASCCP Guidelines Can Work for You
  

  • 

    

    Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA

    Peer

  • 

    

    Leigh Anne Cantrell, MD, MSPH

    Peer

• 

  RestartResume

  Importance of a Timely Postpartum Depression Diagnosis: Patient Perspectives

  Medical Industry Feature

  Importance of a Timely Postpartum Depression Diagnosis: Patient Perspectives

  • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Kay Matthews, LCHW

    Peer

• 

  RestartResume

  Testing Your Advanced Ovarian Cancer Patients for Homologous Recombination Deficiency

  Medical Industry Feature

  Testing Your Advanced Ovarian Cancer Patients for Homologous Recombination Deficiency

  • 

    

    John Nakayama, MD

    Peer

  • 

    

    Joshua Kesterson, MD

    Peer

  • 

    

    Alexander Olawaiye, MD

    Peer

• 

  RestartResume

  Maximizing Flu Protection: The Clinical Value of Cell-Based Vaccines

  Medical Industry Feature

  Maximizing Flu Protection: The Clinical Value of Cell-Based Vaccines

  • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Victoria A. Statler, MD, MSc

    Peer

• 

  RestartResume

  Unraveling the Role of Adjuvanted Flu Vaccines for Older High-Risk Patients

  Medical Industry Feature

  Unraveling the Role of Adjuvanted Flu Vaccines for Older High-Risk Patients

  • 

    

    Stephen I. Pelton, MD

    Peer

• 

  RestartResume

  Adjuvanted Vaccines: The Modern Era in Flu Prevention for Older Adults

  Medical Industry Feature

  Adjuvanted Vaccines: The Modern Era in Flu Prevention for Older Adults

• 

  RestartResume

  Vax Myths Unveiled: Navigating Flu Vaccine Misconceptions

  Medical Industry Feature

  Vax Myths Unveiled: Navigating Flu Vaccine Misconceptions

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Wendy Wright, DNP

    Peer

  • 

    

    Elias Chahine, PharmD, FCCP, FASCP

    Peer

• 

  RestartResume

  Eureka for Influenza Prevention! Cell-Based Vaccines of the Future

  Medical Industry Feature

  Eureka for Influenza Prevention! Cell-Based Vaccines of the Future